Autosomal recessive polycystic kidney disease is caused by mutations in PKHD1, which encodes the membrane-associated receptor-like protein fibrocystin/polyductin (FPC). FPC associates with the primary cilia of epithelial cells and co-localizes with the Pkd2 gene product polycystin-2 (PC2), suggesting that these two proteins may function in a common molecular pathway. For investigation of this, a mouse model with a gene-targeted mutation in Pkhd1 that recapitulates phenotypic characteristics of human autosomal recessive polycystic kidney disease was produced. The absence of FPC is associated with aberrant ciliogenesis in the kidneys of Pkhd1-deficient mice. It was found that the COOH-terminus of FPC and the NH2-terminus of PC2 interact and that lack of FPC reduced PC2 expression but not vice versa, suggesting that PC2 may function immediately downstream of FPC in vivo. PC2-channel activities were dysregulated in cultured renal epithelial cells derived from Pkhd1 mutant mice, further supporting that both cystoproteins function in a common pathway. In addition, mice with mutations in both Pkhd1 and Pkd2 had a more severe renal cystic phenotype than mice with single mutations, suggesting that FPC acts as a genetic modifier for disease severity in autosomal dominant polycystic kidney disease that results from Pkd2 mutations. It is concluded that a functional and molecular interaction exists between FPC and PC2 in vivo.
identical clinical manifestations. Mutations in PKD2, which maps to chromosome 4q21-23, are responsible for approximately 15% of familial ADPKD cases. 4, 5 PKD2 has an approximately 5.4-kb transcript and encodes the 968 -amino acid gene product polycystin-2 (PC2). PC2 is predicted to be an integral membrane protein with six putative transmembrane domains and intracellular NH2-and COOH-termini. 4 PC2 has been reported to be a receptor-operated, nonselective cation channel; it is also referred to as TRPP2, because it is considered a member of the trp superfamily. 6, 7 Conversely, mutations in PKD1 are responsible for approximately 85% of ADPKD cases. PKD1 lies in an approximately 53-kb region on chromosome 16p13.3 and yields a 14-kb transcript that encodes a 4303-amino acid integral membrane protein. 8 The gene product of PKD1, polycystin-1 (PC1), was reported to interact with PC2 and regulate Pkd2-channel activity. 9 -12 ϩ/Ϫ , and Pkhd1 Ϫ/Ϫ mice are shown. The mice in these cohorts were observed for Ͼ1 yr. Survival of the Pkhd1 Ϫ/Ϫ mice differed significantly from that of the WT and Pkhd1 ϩ/Ϫ cohorts (P Ͻ 0.001).
Pkhd1 mutant alleles contained an in-frame GFP reporter gene, we used an anti-GFP antibody to detect GFP expression. GFP immunoreactivity was detected at the expected size of 130 kD in the adult kidneys of Pkhd1 Ϫ/Ϫ and Pkhd1 ϩ/Ϫ mice. (F) Western blot detection of FPC. Antibodies hAR-Cm3C10 and hARNm3G12, which recognize the COOH-and NH2-portions of FPC, respectively, were used to detect immunoreactivity to FPC in the adult kidneys of WT, Pkhd1 ϩ/Ϫ , and Pkhd1 Ϫ/Ϫ mice. FPC expression was significantly reduced in Pkhd1 Ϫ/Ϫ kidneys compared with WT and Pkhd1 ϩ/Ϫ .
ARPKD is one of the common hereditary renal cystic diseases in infants and children. 13 The estimated incidence of ARPKD is approximately 1 in 20,000 live births. 14 The clinical characteristics of ARPKD include ectasia of the renal collecting ducts and hepatic biliary ducts with associated renal and hepatic fibrosis. 15 Approximately 50% of patients with ARPKD present with their disease as neonates 16 and are born with two very large kidneys with 60 to 90% of the renal tubules being ectatic. 15 These neonates suffer a 30% mortality rate as a result of respiratory and/or renal dysfunction. 17 Patients who have ARPKD and survive their first year of life have a more optimistic prognosis: 75% reach age 5, and only half develop ESRD. 16 -18 In rare cases, patients with ARPKD survive beyond age 60. 19 The most common complications of ARPKD include hypertension (60 to 100%), portal hypertension owing to severe hepatic fibrosis or Caroli disease (30 to 75%), and chronic lung disease (approximately 11%). 17 In addition, growth retardation, 15 intracranial aneurysms, 20, 21 and adrenal insufficiency 22 can be seen in patients with ARPKD.
ARPKD is caused by mutations in PKHD1. This gene consists of at least 86 exons spanning 470 kb on chromosome 6p12 and produces a 16-kb transcript. The longest open reading frame is predicted to include 66 exons and to encode the 4074 -amino acid membrane-associated receptor-like protein fibrocystin/polyductin (FPC). [23] [24] [25] [26] It was shown that FPC is associated with the basal bodies/primary cilia of epithelial cells [27] [28] [29] [30] and co-localizes with PC2 within the cell. 31 These observations suggest the possibility that FPC and PC2 may function in a common molecular pathway in vivo.
To investigate a potential functional relationship between FPC and PC2, we generated and characterized a mouse model with a gene-targeted mutation in Pkhd1. We discovered that lack of FPC was associated with the downregulation of PC2 expression in vivo. Renal cyst formation is more severe in mice ) 32, 33 than in mice that are heterozygous for the Pkd2 mutation alone. In addition, we found that Pkd2-channel activities were dysregulated in primary cultures of renal epithelial cells derived from Pkhd1 mutant mice. The in vivo observations demonstrated that FPC and PC2 functionally interacted and resided in a common molecular pathway.
RESULTS

Generation of Pkhd1-Deficient Mutant Mice
Because the Northern probe containing exons 15 to 16 of PKHD1 displayed highly mRNA expression signal in the kidney tissue, we designed a targeting construct that not only disrupted exon 15 but also deleted exon 16, resulting in a mutant allele designated Pkhd1 e15GFP⌬16 (Pkhd1 Ϫ ) ( Figure 1 , A through D). Because our gene-targeting construct included an in-frame green fluorescence protein (GFP) reporter gene with a predicted fusion protein of 130 kD ( Figure 1A ), anti-GFP immunoprecipitation assays showed that only the mutant mice expressed the GFP reporter protein ( Figure 1E ). In addition, with the use of a panel of previously generated anti-FPC antibodies, 31 Western blot analyses were able to detect the expected immunoreactive bands at Ͼ400 kD in the wild-type (WT) and heterozygous mouse kidneys ( Figure 1F ). These immunoreactive bands were not detected in protein lysate from
Pkhd1
Ϫ/Ϫ mouse kidneys, suggesting that the homozygous mice lacked full-length, functional FPC.
Pkhd1-Deficient Mice Exhibit the Phenotypic Characteristics of Human ARPKD
To determine whether the Pkhd1-deficient mice would be a suitable model for ARPKD, we intercrossed heterozygous Pkhd1 mice to produce homozygous (Pkhd1
Ϫ/Ϫ mice were born at a frequency of 18%, lower than the expected Mendelian ratio, indicating a loss of approximately 5 to 10% of the Pkhd1 Ϫ/Ϫ mice during the embryonic or perinatal period (Figure 2A ). This suggests that the Pkhd1 Ϫ/Ϫ genotype may lead to embryonic lethality. Mice that reached adulthood were used in a cohort study. Kaplan-Meier analysis showed that only 25% of Pkhd1 Ϫ/Ϫ mice survived beyond 12 mo compared with 60% of Pkhd1 ϩ/Ϫ mice (P Ͻ 0.001) and 90% of WT mice (P Ͻ 0.001), suggesting that some adult Pkhd1 Ϫ/Ϫ mice died as a result of their disease phenotypes ( Figure 2B ). Although there was a trend toward increased mortality in Pkhd1 ϩ/Ϫ mice compared with WT mice, this did not reach statistical significance (P ϭ 0.075).
Pkhd1 Ϫ/Ϫ mice that escaped embryonic lethality and survived into adulthood exhibited mild to severe tubular dilation or cyst formation in the kidney and liver accompanied by fibrosis and necrosis ( Figure 3 ). The severity of cysts and the age at the onset of disease varied among individual Pkhd1 Ϫ/Ϫ mice. Approximately 10% of the mice had early-onset, microscopic malformations in the renal tubules (Figure 3 , B through G), whereas others (approximately 60%) survived beyond 1 yr and had late-onset cystic phenotypes. The extent of cystic change in the liver of Pkhd1 Ϫ/Ϫ mice was generally more severe than that observed in the kidneys (Figure 3 , H through K). These observations indicate that the targeted mutation in Pkhd1 induces cystogenesis in the kidneys and livers of the mice. Cystic or dilated-duct phenotypes were also seen in the pancreas ( 
Lack of FPC Exhibits Aberrant Ciliogenesis in the Renal Epithelial Cells
FPC was demonstrated to localize to the primary cilium and/or basal bodies of renal tubular epithelia, [27] [28] [29] [30] [31] and malformation of the cilia was shown to induce cyst formation in the kidneys 34, 35 ; therefore, we began to determine whether the lack of FPC also disrupts ciliogenesis in Pkhd1-deficient mice. We used IF with an anti-acetylated ␣-tubulin antibody to examine the number and morphology of renal primary cilia in 6-moold littermates. Compared with WT mice, there were far fewer primary cilia in the renal tubular epithelia of Pkhd1 Ϫ/Ϫ mice ( Figure 6 , A versus B), indicating that lack of FPC might reduce ciliogenesis in the kidneys. The ciliary defects seem to be most severe in the cortical proximal tubules of the Pkhd1 Ϫ/Ϫ kidneys. In addition, confocal images also displayed similar ciliary changes in corresponding regions of littermate kidneys ( Figure  6 , C versus D). Scanning electron microscopy confirmed these results in 3-mo-old littermates with or without the targeted Pkhd1 mutation ( Figure 6 , E versus F). For further validation of these findings, primary culture of renal epithelial cells derived from 2-mo-old Pkhd1 Ϫ/Ϫ and WT littermates was used to determine whether the ciliary malformation could be observed in vitro. Compared with the cultured WT cells, a shortened ciliary structure and decreased ciliary staining were seen in the Pkhd1 Ϫ/Ϫ cells ( Figure 6 , G versus H). The cilia stained in approximately 94% of WT cells and in fewer than 34% of Pkhd1 Ϫ/Ϫ cells (P Ͻ 0.001; Figure 6I ). The mean length of primary cilia was 10 m in cultured WT cells and was Ͻ5 m in Pkhd1 Ϫ/Ϫ littermate cells (P Ͻ 0.001; Figure 6J ). That short or absent cilia were observed in Pkhd1 Ϫ/Ϫ cells but not in WT cells suggests that lack of FPC causes defects in ciliogenesis in renal epithelial cells in vivo. Several in vitro studies from our group and others have shown that FPC and PC2 co-localize to the basal bodies/primary cilia of renal epithelial cells and are able to form a molecular complex and function in the same signaling pathway. 31, 36 For further validation of this finding in vivo, the phenotypic effects of transheterozygosity for Pkhd1 and Pkd2 were examined. We intercrossed Pkhd1 ϩ/Ϫ and Pkd2 ϩ/Ϫ mutant mice to produce cohorts of age-matched littermates. The four genotypes of in-
, and WT) were obtained from live-born progeny. Cohorts were killed at 1 mo. Gross inspection did not reveal cysts on the surface of the kidneys in any of the genotypes.
Because spherical renal cysts (at least three times the normal diameter of the proximal tubule) are characteristic of ADPKD and massive, dilated, spindle-shaped renal tubules are more typical of the ARPKD phenotype, we used sphere-shape cysts to represent ADPKD-like renal cysts. [1] [2] [3] In mice with Pkhd1 
FPC and PC2 Interact In Vivo and Form a Molecular Complex in Renal Epithelia
Because a lack of FPC inhibited the expression of PC2 and induced severe cystic phenotypes in the Pkhd1 (Figure 7) , we decided to analyze the molecular relationship between FPC and PC2. We used our mAb hPKD2-Cm1A11, which is directed against the intracellular COOHterminus of PC2, to examine protein level in tissue lysates from WT, Pkhd1 ϩ/Ϫ , and Pkhd1 Ϫ/Ϫ littermates at embryonic day 13.5 (E13.5). Compared with WT embryos, PC2 expression was decreased in the Pkhd1 Ϫ/Ϫ embryos, suggesting that lack of FPC downregulates PC2 expression in vivo ( Figure 8A ). In addition, IHC staining with the anti-PC2 polyclonal antibody hPKD2-Cp was used to examine expression level of PC2 in the Pkhd1 Ϫ/Ϫ 1-mo-old kidneys. In the renal cortex, significantly less staining was observed in Pkhd1 Ϫ/Ϫ kidneys than in WT littermates ( Figure 8B ), giving further evidence that lack of FPC disrupts normal PC2 expression in vivo; however, quantitative PCR did not reveal a significant difference in Pkd2 expression among Pkhd1 Figure 8C ). In addition, we used tissue lysates from an E13.5 Pkd2-mutant set in another co-IP assay. Similar to the previous result, FPC immunoprecipitated with PC2 in tissue from WT and Pkd2 ϩ/Ϫ littermates but not in tissue from Pkd2 Ϫ/Ϫ littermates ( Figure 8D ). Immunoreactivity was stronger in WT than in heterozygous littermates and was not detected in homozygous littermate controls, providing strong evidence that FPC may physically interact with PC2 in vivo. It is interesting that no reduction of FPC expression was seen in Pkd2 Ϫ/Ϫ littermates by Western analysis, suggesting that lack of PC2 does not affect the level FPC in vivo ( Figure  8E ).
We constructed serial Hemagglutinin (HA) and Flag-tagged expression vectors that contain intracellular portions of FPC and PC2, respectively. Positive immunoreactivity was seen in co-IP assays between the COOH-terminal portion of FPC (FPC-CFlag) and the NH2-terminal portion of PC2 (PC2-N-HA; Figure  8F ). Immunoreactivity was not observed between COOH-terminal portions of FPC (FPC-C-Flag) and PC2 (PC2-C-HA; data not shown). This suggests that the interaction between FPC and PC2 occurs via the intracellular COOH-terminal tail of FPC and NH2-terminal portion of PC2. For confirmation of this, HEK293 cells were transiently co-transfected with both an expression vector containing the full-length human PKD2 cDNA (PC2-Full) and the aforementioned FPC-C-Flag vector. With the use of an anti-PC2 antibody to immunoprecipitate and an anti-Flag antibody for detection by Western blot, a strong band was seen in lysate from the co-transfected cells. Weak immunoreactivity was observed in lysate from cells that were transfected only with FPC-CFlag. These data suggest that FPC-C-Flag can be co-immunoprecipitated with either PC2 introduced exogenously or PC2 endogenous to HEK293 cells ( Figure 8G ). In addition, when lysates from FPC-C-Flag-transfected HEK293 cells were preincubated with an antibody against the COOH-terminal tail of FPC (hAR-C2p), the detection of PC2-N-HA and FPC-C-Flag co-IP was blocked ( Figure 8H ). This result provides further evidence of a specific interaction between the C-terminal tail of FPC and the N-terminal portion of PC2.
Lack of Pkhd1 Disrupts Pkd2-Induced Cation Channel Activities
To study further whether FPC and PC2 functionally interact, we used whole-cell patch clamp recordings to characterize Pkd2-channel activities in Pkhd1-deficient cells. We first tested whether Pkd2-induced whole-cell current could be detected under published conditions 37, 38 and then investigated whether the recorded channel-like current is Pkd2-specific. First, pri- Ϫ/Ϫ embryos were tested to determine whether whole-cell current densities were dysregulated by the lack of Pkd2. The recorded current from the Pkd2 Ϫ/Ϫ fibroblasts was significantly lower than that from the WT fibroblasts at all voltages tested, indicating that reduction of functional channel activities is caused by missing Pkd2 expression (P Ͻ 0.005; Figure 9A ). Next, we used the same approach to test the Pkhd1-silenced inner medullary collecting duct (IMCD) cells (IMCD shRNA3e23 ) and WT control cells (IMCD sh15 ) that we had generated previously. 39 It is interesting that Pkhd1-silenced IMCD cells exhibited a similar channel reduction, indicating that inhibition of FPC also Ϫ/Ϫ littermates were used to perform a co-IP Western using the anti-FPC antibody hAR-Nm3G12 to IP and the anti-PC2 antibody hPKD2-Cm1A11 to detect PC2 expression. Positive immunoreactivity was seen in the WT embryo, and progressively reduced immunoreactivities were seen in the Pkhd1 ϩ/Ϫ and Pkhd1 Ϫ/Ϫ littermates, suggesting that FPC binds to PC2 in vivo. (D) Lysates from E13.5 WT, Pkd2 ϩ/Ϫ , and Pkd2 Ϫ/Ϫ littermates were used to perform a co-IP Western using the anti-PC2 antibody to IP and the anti-FPC antibody to detect FPC expression. Positive immunoreactivity was seen in the WT and Pkd2 ϩ/Ϫ littermates, but no immunoreactivity was observed in the Pkd2 Ϫ/Ϫ littermate, providing further evidence that FPC physically interacts with PC2 in vivo. (E) There was no change in FPC expression in Western blot analysis among the WT and Pkd2 Ϫ/Ϫ littermates, indicating that the downregulation of PC2 does not affect FPC expression. (F) HA-and Flag-tagged expression vectors, in which the COOH-terminus of FPC (FPC-C-Flag) and the NH2-terminus of PC2 (PC2-N-HA) were constructed in-frame, were transiently co-transfected into HEK293 cells. Using an anti-Flag antibody to IP and an anti-HA antibody to detect the NH2-terminus of PC2, positive immunoreactivity was seen only in the co-transfected sample, indicating that the COOH-terminus of FPC physically interacts with the NH2-terminus of PC2 in vitro. (G) The same FPC-C-Flag expression vector was transiently co-transfected into HEK293 cells with an expression vector containing the human full-length PKD2 cDNA (PC2-Full). The anti-PC2 antibody hPKD2-Cm1A11 was used for IP and an anti-Flag antibody was used to detect the COOH-terminus of FPC. Strong positive immunoreactivity was seen only in the co-transfected sample, and weak immunoreactivity was detected in the FPC-C-Flag single-transfected sample, indicating that either exogenously transfected or endogenously expressed PC2 immunoprecipitates with FPC-C-Flag construct. This further confirms that the COOH-terminus of FPC physically interacts with the NH2-terminus of PC2. (H) Using the hAR-C2p antibody against the COOH-terminus of FPC to preincubate with FPC-C-Flag singletransfected protein lysates, positive immunoreactivity was seen only in the nonpreincubated co-IP sample, whereas the immunoreactivity was missing in the preincubated co-IP sample. Bar ϭ 30 m in B.
reduces Pkd2-channel activities (P Ͻ 0.001; Figure 9 , Bb versus Bc). For verification that the functional channel changes were induced by missing Pkd2, the anti-PC2 polyclonal antibody hPKD2-Cp, which recognizes the intracellular COOH-terminal region of PC2, was transferred into WT control IMCD sh15 cells via pipette solution. The current density was significantly inhibited in IMCD sh15 cells that were treated with hPKD2-Cp antibody (P Ͻ 0.02; Figure 9 , Bb versus Be), suggesting that the current change is Pkd2 specific. To validate our findings further, we produced primary cultures of renal epithelia from 2-mo-old WT and Pkhd1 Ϫ/Ϫ kidneys. Whole-cell current densities were significantly decreased in Pkhd1 Ϫ/Ϫ cells compared with WT cells (P Ͻ 0.003; Figure 9C ), indicating that lack of FPC also inhibits Pkd2-specific channel activities. For clarifi- littermates, suggesting that the cation channel activity is induced by lack of PC2 (n ϭ 10; *P Ͻ 0.005). (B) A Pkhd1-knockdown stable cell line IMCD shRNA3e23 and its WT-controlled cell line IMCD sh15 were used to perform the whole-cell current recording assays under the same conditions. Currents were elicited by stepping from a holding potential of 0 mV to various test potentials (Ba). The current densities between IMCD shRNA3e23 (n ϭ 12) and IMCD sh15 (n ϭ 7) cells exhibited a statistically significant difference (Bb versus Bc; *P Ͻ 0.001). The control IMCD sh15 cells displayed a steep inwardly rectifying current, which was significantly reduced by the intracellular introduction of the anti-PC2 C-terminal antibody hPKD2-Cp via pipette solution at a dilution of 1:200 (n ϭ 8; Bb versus Be; #P Ͻ 0.02), suggesting that the current changes are PC2 specific. (C) Primary cultured renal epithelial cells derived from 2-mo-old WT (WT) and Pkhd1 Ϫ/Ϫ littermates were used to perform the same whole-cell current recording assays. The control WT cells (n ϭ 15) displayed a steep inwardly rectifying current, which was substantially reduced in Pkhd1 Ϫ/Ϫ cells (n ϭ 7). This indicates that the whole-cell current density in cells from the Pkhd1 Ϫ/Ϫ mice is significantly lower than in those from the WT littermates (*P Ͻ 0.003). (D) hPKD2-Cp and a negative control anti-actin antibody were each added intracellularly into separate WT cells via pipette solution. Representative current traces were not clearly reduced in the cells with anti-actin antibody (n ϭ 6), but a substantially smaller current amplitude was seen in the cells with hPKD2-Cp antibody (n ϭ 8; #P Ͻ 0.01), further suggesting that the current alteration between WT and Pkhd2 Ϫ/Ϫ cells in C is Pkd2 specific. (E) For unequivocal validation that the inhibited current density seen in the Pkhd1 Ϫ/Ϫ cells is due to lack of FPC expression, a human full-length PKHD1 cDNA was in-frame constructed into a GFP-tagged expression vector and was transiently transfected into the Pkhd1 Ϫ/Ϫ cells. GFP-positive cells were chosen to perform the whole-cell current recording (n ϭ 4), and current density-voltage plots showed that the re-expression of FPC rescues the inhibited current density seen in the Pkhd1 Ϫ/Ϫ cells (Pkhd1 Ϫ/Ϫ -C versus Pkhd1 Ϫ/Ϫ ; #P Ͻ 0.01). The dashed line represents the mean I-V curve from the Pkhd1 Ϫ/Ϫ cells in C, and the dotted line shows the means I-V curve from the WT cells in C. Currents were measured 220 ms after stepping to the test potential. Data are means Ϯ SEM from the tested independent cells. Statistical difference at *ϩ80 and #ϩ100 mV between the tested cell groups. The data were fitted with standard Boltzmann equation (I ϭ I max /1 Ϫ e (V50 Ϫ V)/k) ϩ C).
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cation that the downregulated current in Pkhd1 Ϫ/Ϫ primary cultured cells was due to the Pkd2-specific channel, the wholecell current of WT primary cultured cells was recorded in the presence of either the anti-PC2 antibody hPKD2-Cp or an anti-actin antibody. As representative current records and I-V curves in Figure 9D show, the anti-PC2 antibody reduced the current density, but the anti-actin antibody did not, confirming that the whole-cell current was conducted through Pkd2 channels.
To obtain unequivocal evidence that the whole-cell current changes were induced by downregulation of FPC, we further investigated whether re-expression of FPC could rescue the reduced channel activities seen in Pkhd1 Ϫ/Ϫ cells ( Figure 9C ). We transiently transfected primary cultured Pkhd1 Ϫ/Ϫ cells with a mammalian expression vector, pcDNA3.1/Hygro, containing the full-length ORF cDNA of human PKHD1 with GFP fused in-frame. GFP-positive Pkhd1 Ϫ/Ϫ cells, named Pkhd1 Ϫ/Ϫ -C, were chosen for the whole-cell current recording assay. As shown in Figure 9E , both the current density and I-V relation of Pkhd1 Ϫ/Ϫ -C cells were used to compare the currents recorded from WT (dotted line) and Pkhd1 Ϫ/Ϫ cells (dashed line; Figure 9C ). Unlike Pkhd1 Ϫ/Ϫ cells, the current density of Pkhd1 Ϫ/Ϫ -C cells was similar to WT cells ( Figure  9E) , indicating that the current changes between WT and Pkhd1 Ϫ/Ϫ cells are due to downregulation of FPC. That inhibition of Pkhd1 expression disrupts Pkd2-specific channel activities gives further evidence to demonstrate FPC and PC2 function in the same molecular pathway.
DISCUSSION
Although the gene responsible for ARPKD, PKHD1, has been identified [23] [24] [25] and its gene product, FPC, has been initially characterized, 27, 28, 30, 31, 39, 40 the mechanisms by which PKHD1 causes disease phenotypes remain largely unknown. To study the disease mechanism and pathogenesis of ARPKD, we created a mouse that allows manipulation of Pkhd1, an animal model that recapitulates the human ARPKD phenotype. Through genetic and biochemical studies, we demonstrated that the COOH-terminus of FPC physically interacts with the NH2-terminus of PC2 and that lack of FPC leads to downregulation of PC2 expression in vivo. Transmutant mice for Pkhd1 and Pkd2 displayed a significantly more severe renal cystic phenotype than single-mutant mice, suggesting that Pkhd1 serves as a disease modifier for ADPKD. For functional validation of these findings, Pkd2-channel activities were examined both in primary cultures of renal epithelia derived from Pkhd1 mutant mice and in Pkhd1-silenced IMCD cells. 39 Pkd2-channel activities were significantly dysregulated in Pkhd1-deficient cells, indicating that FPC and PC2 reside in the same molecular pathway. During submission of our article, another group reported that there are genetic interactions between Pkhd1 and Pkd1. 41 Because the gene product of PKD1, PC1, was reported to interact with PC2 and regulate Pkd2-channel activity, 9 -11 our findings combined with theirs draw the conclusion that ADPKD and ARPKD may reside in the same pathogenic pathway.
In this study, the Pkhd1 Ϫ/Ϫ genotype seemed to cause embryonic lethality; however, a phenotypic analysis of these Pkhd1 Ϫ/Ϫ embryos did not show any significant cardiac defects and only mild edema, which was prevalent in the Pkd2 mutant mice. Because Pkd2 Ϫ/Ϫ mice are embryonically lethal, the finding that a lack of FPC promotes a significant downregulation of PC2 expression raises the possibility that partial embryonic lethality in Pkhd1 Ϫ/Ϫ mice may be caused by this reduction of PC2.
We previously reported that FPC and PC2 co-localize to the same subcellular organelles, the basal bodies/primary cilia of renal epithelial cells, 31 suggesting that these two cystoproteins may form a molecular complex. Recent reports have shown that the same chemical molecule (a vasopressin V2 receptor antagonist, OPC31260) can inhibit cyst progression in both a rat genetic model of ARPKD and a mouse genetic model of ADPKD, suggesting that both causal gene products for AD-PKD and ARPKD may reside in a common molecular pathway. 42 Recently, our company study demonstrated that FPC and PC2 indirectly interact via their COOH-termini and that this is mediated by KIF3B, a motor subunit of the heterotrimer kinesin-2. 36 Pkd2-channel activities were significantly altered when the FPC-PC2 complex was disrupted. This in vitro study provides a molecular basis for a functional link between FPC and PC2. Another recent report that supports a functional link suggests that FPC regulates mechanotransduced Ca 2ϩ responses, which may be induced by PC2, in cultured Pkhd1-knockdown cells. 43 In this study, the evidence that the COOHterminus of FPC directly interacts with the NH2-terminus of PC2 suggests that FPC and PC2 are able physically to form a heterodimeric complex in vivo. Lack of FPC downregulates Pkd2-channel activities in either the Pkhd1-knockout renal epithelial cells in primary culture or the Pkhd1-knockdown IMCD cells that we generated previously. 39 Given that FPC and PC2 physically interact and that the lack of FPC downregulates PC2 expression in vivo but PC2 does not downregulate FPC, we speculate that PC2 may function immediately downstream of FPC.
The disruption of ciliary formation in renal epithelia induces cystogenesis in the kidneys. 34, 35 We recently reported that downregulation of Pkhd1 significantly decreases ciliary formation in cultured Pkhd1-silenced IMCD cells, suggesting that lack of FPC might disrupt ciliogenesis in renal epithelial cells. This result is consistent with studies in which transient small interference RNA-mediated inhibition of Pkhd1 in cholangiocytes resulted in shortening and decreased formation of cilia, 29 but spatial and environmental differences between in vivo tissues and in vitro cell culture may lead to different results. Mouse models with a deletion of Pkhd1 exon 40 44 and genetargeted mutations in Pkd2 that cause distinct liver and/or kidney cysts 33, 45, 46 do not exhibit defects in ciliary structure in the affected epithelial cells, suggesting that the failure of renal epithelia to assemble primary cilia may not be the only factor leading to cyst formation in the kidneys. For example, a recent study showed that disruption of the extracellular matrix protein laminin ␣5, which is a major component of the tubular and glomerular basement membranes, also produces cystic kidneys in Lama5 mutant mice. 47 By carefully examining ciliogenesis in our Pkhd1 mutant kidneys, we found that primary cilia of the cortical tubular epithelia were reduced in number and were shorter than controls, documenting that disruption of FPC expression induces malformation of the primary cilia in the kidneys in vivo. Recently, an elegant study demonstrated that disruption of FPC expression causes defective planar cell polarity in another Pkhd1 genetic model, the pck rat. Spindle orientation in the renal epithelial cells of the pck rat is aberrant, suggesting that cell polarity is disrupted during mitosis of renal epithelial cells. 48 Our previous in vitro study also demonstrated that renal epithelial IMCD cells with downregulated FPC exhibit aberrant migratory polarity and lose the ability to drive collective cell migration, suggesting that the planar cell polarity also might be disrupted. 39 Aberrant planar cell polarity seen in cells with Pkhd1 defects suggests that ciliary defects in our Pkhd1 mutant mice might be caused by impeding orientally centriole arrangement and disabling the establishment of epithelial polarity. 39, 49 Because our Pkhd1 mutant mice bear an in-frame GFP reporter, immunostaining with anti-GFP antibodies provided an FPC expression profile in affected tissues. Positive GFP expression was detected in the apical domain of epithelial derivatives, including the renal, hepatic, pulmonary, and gastrointestinal epithelia as well as ependymal cells lining the ventricles of the brain. These findings are consistent with our previous report 31 and indicate that FPC may modulate the morphogenesis and maintenance of tubular/ductal architectures in organs generated from the primary duct system. 50 Several recent studies indicated that FPC is involved in notch-like processing and that its extremely large extracellular domain is released from the primary cilia of renal epithelial cells. 51 That GFP-positive signals were detected at the microvilli of tubular epithelia in our Pkhd1 Ϫ/Ϫ mice agrees with the report that FPC may be released into the tubular/ductal lumen.
In summary, we produced a mouse model for Pkhd1 that recapitulates the phenotypic characteristics of human ARPKD. Using this model along with a Pkd2 mutant mouse, we were able to demonstrate the importance of FPC expression for normal PC2 function. The finding of aberrant ciliogenesis in the kidneys of Pkhd1-deficient mice indicates that FPC disrupts the process of ciliogenesis. That FPC physically interacts with PC2 and that lack of FPC destabilizes PC2 expression in vivo but not vice versa suggest that PC2, also known as TRPP2, functions immediately downstream of FPC. In addition, because inhibition of FPC expression reduces Pkd2-channel activity, we conclude that a functional and molecular interaction exists between FPC and PC2 in vivo. Extracellular biochemical and/or physical signals may activate the receptor-like protein FPC, which then triggers TRPP2 channel to transmit signals that affect intracellular processes. Our in vivo study reveals an intriguing molecular relationship between FPC and PC2.
CONCISE METHODS
Mouse Strains
The gene-targeted mouse model for Pkd2 (Pkd2 tm2Som ) was previously generated by us. 32, 33 To produce mutant mice for Pkhd1, we designed a targeting construct disrupting its 15th coding exon (Figure 1 ). We found 620 embryonic stem cell colonies resistant to G418, with one (W4A5) identified by PCR screening using a pair of outside-construct and cassette-based primers. This cell line was further confirmed by Southern blot analysis and injected into C57Bl/6 blastocysts at the gene targeting and transgenic facility of University of Connecticut Health Center.
Southern and Northern Blotting and Quantitative PCR
Southern analysis was used to genotype Pkhd1 and Pkd2 mutant mice with our published approaches. 32, 52 For Northern analysis, total RNA was isolated from embryos or kidneys using Trizol reagent (Invitrogen, Carlsbad, CA) following the manufacturer's instructions. Probes were labeled using the RadPrime DNA-labeling system (Invitrogen) with ␣-32P-dCTP (PerkinElmer, Waltham, MA) and were hybridized with total RNA blots (25 g/lane). Images of 28-S rRNA bands in these same blots were used as a total RNA loading control.
Quantitative PCR was performed using the iCycler iQ RealTime PCR Detection System with iQ SYBR Green Supermix kit (Bio-Rad, Hercules, CA). Two pairs of primers were designed from each cDNA sequence of Pkhd1 and Pkd2 (Table 1) .
Antibodies
Polyclonal antibodies and mAb against FPC (including hARNp, hAR-C2p, hAR-Nm3G12, and hAR-C2m3C10) and antibodies against human PC2 (hPKD2-Cp and hPKD2-Cm1A11, formerly named PKD2A11) were described in our previous studies. 31, 36 In addition, other polyclonal antibodies and mAb were purchased: Anti-acetylated ␣-tubulin, anti-␥-tubulin, anti-␤-actin, anti-Flag, and anti-HA mAb (Sigma, St. Louis, 
Western Blotting and Immunoprecipitation
For Western analysis and immunoprecipitation, the detailed approaches were similar to our previous publications. 31, 36, 39 For performance of co-IP and Western analysis, the entire intracellular termini of FPC and PC2 were constructed into Flagtagged and HA-tagged pCMV expression vectors 53 and were named FPC-C-HA (amino acids 3872 to 4074), PC2-N-HA (amino acids 1 to 221), and PC2-C-Flag (amino acids 682 to 968). To index cystic disease severity, we calculated the total number of cysts using four histologic sections from each kidney. Detailed procedures for histology, IF, and IHC were published previously. 31 For confocal microscopy, antibody-stained images were collected as Z-series sections using a Zeiss LSM 510 confocal microscope system with ϫ40, ϫ63, and ϫ100 oil objectives. For scanning electron microscopy, mice were perfused as described previously. 31 The kidneys were removed, sectioned longitudinally, washed by 1ϫ PBS three times, and fixed in 2.5% paraformaldehyde. After an ethanol dehydration series, the samples were critical-point dried and sputter-coated with 40% gold/60% palladium microparticles to a thickness of 15 to 17 mm. Images of the samples were obtained using an Electroscan E3 Environmental Scanning Electron Microscope.
Cell Lines and Mouse Kidney Primary Epithelial Cultures
All cell lines used in this study were cultured under previously described conditions. 39 To generate primary cultures of renal epithelia, we removed kidneys from 2-mo-old WT or Pkhd1 mutant mice and minced them finely with a scalpel. The minced tissue was incubated with 0.5% collagenase type IV at 37°C for 45 min and pipetted vigorously. The undigested tissue was removed by filtration through a 40-mesh filter. The remaining single cells and small organoids were washed three times with PBS containing 5 mM glucose. The cells were incubated with 10 g/ml biotinylated Dolichos biflorus agglutinin (Vector; B-1035) at 4°C for 60 min. Then the cells were washed again with PBS before incubation with 50 l of CELLectin Biotin binder Dynabeads (Invitrogen) at 4°C for 30 min. Because Dynabeads are superparamagnetic polystyrene beads, the incubated mixtures were washed twice with PBS containing 5 mM glucose using a magnetic rack. The cells were eluted with release buffer and were plated on 24-well dishes with 10% FCS DMEM under 5% CO 2 at 37°C.
Statistical Analyses
The survival rate was determined by observing the cohorts of mice daily. We analyzed the survival using the Kaplan-Meier function in the R Software. Graphical data are presented as means Ϯ SD. Statistical analysis was performed where appropriate using the t test or one-way ANOVA followed by Tukey multiple comparison test. Differences with P Ͻ 0.05 were considered statistically significant.
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